United Therapeutics (UTHR) Misses Q4 EPS by 49c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $494.63 --0%
EPS Growth %: -10.1%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -10.1%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $6.19, $0.49 worse than the analyst estimate of $6.68. Revenue for the quarter came in at $735.9 million versus the consensus estimate of $739.92 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- RBC Capital Reiterates Sector Perform Rating on ExxonMobil (XOM)
- H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
